Letrozole (West-Ward Pharmaceuticals Corp.)
Welcome to the PulseAid listing for the Letrozole drug offered from West-Ward Pharmaceuticals Corp.. This Aromatase Inhibitor [EPC],Aromatase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | West-Ward Pharmaceuticals Corp. |
NON-PROPRIETARY NAME: | Letrozole |
SUBSTANCE NAME: | LETROZOLE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Aromatase Inhibitor [EPC],Aromatase Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2011-06-03 |
END MARKETING DATE: | 2019-01-30 |
Letrozole HUMAN PRESCRIPTION DRUG Details:
Item Description | Letrozole from West-Ward Pharmaceuticals Corp. |
LABELER NAME: | West-Ward Pharmaceuticals Corp. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 2.5(mg/1) |
START MARKETING DATE: | 2011-06-03 |
END MARKETING DATE: | 2019-01-30 |
PRODUCT ID: | 0054-0269_58547598-c747-4b82-9292-e765996920b0 |
PRODUCT NDC: | 0054-0269 |
APPLICATION NUMBER: | ANDA090838 |
Other LETROZOLE Pharmaceutical Manufacturers / Labelers: